UniProt ID | OTUB1_RAT | |
---|---|---|
UniProt AC | B2RYG6 | |
Protein Name | Ubiquitin thioesterase OTUB1 {ECO:0000250|UniProtKB:Q7TQI3} | |
Gene Name | Otub1 {ECO:0000312|EMBL:AAI66771.1} | |
Organism | Rattus norvegicus (Rat). | |
Sequence Length | 271 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Hydrolase that can specifically remove compared to 'Lys-48'-linked conjugated ubiquitin from proteins and plays an important regulatory role at the level of protein turnover by preventing degradation. Regulator of T-cell anergy, a phenomenon that occurs when T-cells are rendered unresponsive to antigen rechallenge and no longer respond to their cognate antigen. Acts via its interaction with RNF128/GRAIL. Surprisingly, it regulates RNF128-mediated ubiquitination, but does not deubiquitinate polyubiquitinated RNF128. Deubiquitinates estrogen receptor alpha (ESR1). Mediates deubiquitination of 'Lys-48'-linked polyubiquitin chains, but not 'Lys-63'-linked polyubiquitin chains. Not able to cleave di-ubiquitin. Also capable of removing NEDD8 from NEDD8 conjugates, but with a much lower preference compared to 'Lys-48'-linked ubiquitin (By similarity).; Plays a key non-catalytic role in DNA repair regulation by inhibiting activity of RNF168, an E3 ubiquitin-protein ligase that promotes accumulation of 'Lys-63'-linked histone H2A and H2AX at DNA damage sites. Inhibits RNF168 independently of ubiquitin thioesterase activity by binding and inhibiting UBE2N/UBC13, the E2 partner of RNF168, thereby limiting spreading of 'Lys-63'-linked histone H2A and H2AX marks. Inhibition occurs by binding to free ubiquitin: free ubiquitin acts as an allosteric regulator that increases affinity for UBE2N/UBC13 and disrupts interaction with UBE2V1. The OTUB1-UBE2N/UBC13-free ubiquitin complex adopts a configuration that mimics a cleaved 'Lys48'-linked di-ubiquitin chain (By similarity).. | |
Protein Sequence | MAAEEPQQQKQEPLGSDSEGVNCLAYDEAIMAQQDRIQQEIAVQNPLVSERLELSVLYKEYAEDDNIYQQKIKDLHKKYSYIRKTRPDGNCFYRAFGFSHLEALLDDSKELQRFKAVSAKSKEDLVSQGFTEFTIEDFHNTFMDLIEQVEKQTSVADLLASFNDQSTSDYLVVYLRLLTSGYLQRESKFFEHFIEGGRTVKEFCQQEVEPMCKESDHIHIIALAQALSVSIQVEYMDRGEGGTTNPHVFPEGSEPKVYLLYRPGHYDILYK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAEEPQQQ ------CCCCCHHHH | 24.47 | - | |
16 | Phosphorylation | QKQEPLGSDSEGVNC HCCCCCCCCCCCCCC | 45.72 | 29779826 | |
18 | Phosphorylation | QEPLGSDSEGVNCLA CCCCCCCCCCCCCHH | 37.64 | 27097102 | |
26 | Phosphorylation | EGVNCLAYDEAIMAQ CCCCCHHHHHHHHHH | 11.02 | 25403869 | |
71 | Ubiquitination | DDNIYQQKIKDLHKK CCCCCHHHHHHHHHH | 35.88 | - | |
91 | S-nitrosocysteine | KTRPDGNCFYRAFGF CCCCCCCHHHHHCCH | 3.76 | - | |
91 | S-nitrosylation | KTRPDGNCFYRAFGF CCCCCCCHHHHHCCH | 3.76 | 21278135 | |
109 | Acetylation | EALLDDSKELQRFKA HHHHCCCHHHHHHHH | 70.23 | 22902405 | |
109 | Ubiquitination | EALLDDSKELQRFKA HHHHCCCHHHHHHHH | 70.23 | - | |
188 | Acetylation | GYLQRESKFFEHFIE CHHHHHHHHHHHHHH | 49.69 | 22902405 | |
199 | Phosphorylation | HFIEGGRTVKEFCQQ HHHHCCHHHHHHHHH | 38.92 | 23984901 | |
201 | Ubiquitination | IEGGRTVKEFCQQEV HHCCHHHHHHHHHHH | 44.45 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of OTUB1_RAT !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of OTUB1_RAT !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of OTUB1_RAT !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...